XBiotech (XBIT) Other financing activities (2015 - 2024)

XBiotech has reported Other financing activities for 9 years, with the latest figure at $33000.0 in Q4 2024.

• On a quarterly basis, Other financing activities changed N/A year-over-year to $33000.0 in Q4 2024; TTM through Sep 2025 was $33000.0, a 80.24% decrease from a year earlier, with the FY2024 full-year figure at $200000.0, up 3900.0% from the prior year.
• Other financing activities was $33000.0 for Q4 2024 at XBiotech, down from $64000.0 in the prior quarter.
• The five-year high for Other financing activities was $7.9 million in Q1 2020, with the low at -$150000.0 in Q4 2020.
• Average Other financing activities over 4 years is $1.4 million, with a median of $64000.0 recorded in 2024.
• The largest YoY upside for Other financing activities was 3859.0% in 2020 against a maximum downside of 105.78% in 2020.
• Over 4 years, Other financing activities stood at -$150000.0 in 2020, then jumped by 122.0% to $33000.0 in 2021, then plunged by 84.85% to $5000.0 in 2023, then jumped by 560.0% to $33000.0 in 2024.
• The last three Other financing activities figures came in at $33000.0 (Q4 2024), $64000.0 (Q3 2024), and $48000.0 (Q2 2024), per Business Quant data.